A proposal that would have weakened Eli Lilly and Co.’s defenses against an unwanted takeover failed to pass Monday despite a large majority of shareholders voting to remove those barriers for the second straight year.
Eli Lilly and Co. spends a lot of time these days telling the rest of the story—how well it’s doing in areas not connected to highly lucrative drugs about to see their patents expire. But for the most part, investors and analysts just want to know when the next blockbuster will be coming.
Eli Lilly and Co.’s first-quarter profit beat the expectations of Wall Street analysts, but its stock price slipped anyway Monday morning, along with the broader market.
First-quarter profit fell at Eli Lilly and Co. as the company recorded restructuring charges due to its downsizing and higher research costs as it tries to develop new drugs to help it shrug off its looming patent expirations.
Indiana Tobacco Prevention and Cessation officials acknowledge they still have work to do in a state that in 2008 had the nation's highest smoking rate and still has more than 1 million smokers.
Eli Lilly and Co. Inc. said Friday that the FDA has asked the drugmaker to conduct another clinical trial of its proposed pancreas drug before it resubmits an application to have the drug approved for sale.
The U.S. Justice Department says CVS Pharmacy Inc. has agreed to pay $17.5 million to settle allegations it overcharged Medicaid programs in 10 states, including Indiana.
The Indianapolis-based hospital system plans to sell $228.2 million in bonds this week to refinance existing debt and pay to finish construction of its Saxony hospital in Fishers, set to open late this year.
The drug awaits final action by the European Commission, which has the authority to approve medicines for the European Union. The Commission usually makes a decision on CHMP recommendations within two to three months.
Indianapolis insurer Baldwin & Lyons Inc. stands to lose $15.5 million as a result of the earthquake and tsunami in Japan, as well as other disasters in Australia and New Zealand.
Physicians, dentists, nurses, veterinarians, pharmacists and other medical workers would have to undergo a criminal background check when applying for a new state license under a bill approved Tuesday by an Indiana House committee.
The Carmel-based life and health insurer more than doubled CEO Jim Prieur’s compensation, and also gave increases ranging from 44 percent to 89 percent to other top executives.
Officials from Indiana Medicaid and a hospital trade group are trying to craft a deal that would create a tax on hospitals that would help attract more federal funds for hospitals—thereby offsetting looming cuts in state payments.
The Indianapolis-based health care company’s stock, which trades on the NYSE Amex Equities exchange, has closed at an average price of less than 20 cents over a consecutive 30-day trading period, triggering the warning.
Dan Ferber is a freelance magazine writer in Indianapolis who writes about science, health and the environment for such publications as Science, Popular Science, New Scientist, Audubon, and Women's Health. He co-authored a new book with Harvard Medical School's Dr. Paul Epstein titled "Changing Planet, Changing Health: How the Climate Crisis Threatens Our Health and What We Can Do about It." It was published this month.
The total annual cost for one researcher at Lilly might run $300,000 to $350,000 a year. The figure at Crown Bioscience is one-third of that, said a company executive.
An Indianapolis insurance brokerage disciplined for unauthorized legal practice might now face millions of dollars in claims from more than 4,000 former clients because of a class-action suit filed in Marion Superior Court.
TechPoint-led initiative is meant to help bring inventions to market by giving them a trial in real-world setting.
A Michigan insurance company is seeking to avoid paying for any claims made by Mavris Arts & Event Center in Indianapolis involving a high-profile fatal wedding-shuttle accident last summer.
All publicly traded companies have to allow advisory votes about top executives compensation every two or three under the Dodd-Frank financial reform passed by Congress last year.
